GIVLAARI
givosiran sodium
Listed by Alnylam Pharmaceuticals, Inc.
- Strength
- 189 mg/mL
- Form
- Injection, Solution
- Route
- Subcutaneous
- Class
- Aminolevulinate Synthase 1-directed RNA Inter…
What it contains
- Givosiran Sodium 189 mg/mL
FDA record
| Dosage form | Injection, Solution |
|---|---|
| Route | Subcutaneous |
| Drug class | Aminolevulinate Synthase 1-directed RNA Interaction; Small Interfering RNA |
| Approval route | NDA — original brand approval |
| NDC code | 71336-1001 |
| FDA application | NDA212194 |
| RxNorm concept | 2265716 |
| Package sizes listed | 1 |
| Marketed since | December 2019 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.